Ever-Growing USA on MSN6h
Cell Line Development Process – Challenges and Best Practices
Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.
IQVIA Holdings Inc. (NYSE:IQV) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, ...
The Attention Alchemists: crafting gold from social engineering
Nike's 2018 campaign featuring Colin Kaepernick is a masterclass in corporate social alchemy. By embracing the controversial ...
Scientists achieve optical control of phase and group velocities in everyday liquids
The phase and the group velocity of light propagating in conventional optical media cannot exceed the speed of light in ...
Maze Therapeutics doses first patient in Phase 2 HORIZON trial
Maze Therapeutics (MAZE) announced the first patient has been dosed in the company’s Phase 2 clinical trial, the HORIZON Study, of MZE829 in ...
Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...
precisionmedicineonline11h
Maze Therapeutics Doses First Patient in Phase II APOL1 Inhibitor Kidney Disease Trial
Within the open-label basket trial, patients with two copies of one of two high-risk APOL1 gene variants will receive MZE829.